The glycosylation of human serum IgD and IgE and the accessibility of identified oligomannose structures for interaction with mannan-binding lectin.

The glycosylation of human serum IgD and IgE and the accessibility of identified oligomannose structures for interaction with mannan-binding lectin.

Analysis of the glycosylation of human serum IgD and IgE indicated that oligomannose structures are present on both Igs. The relative proportion of the oligomannose glycans is consistent with the occupation of one N-linked site on each heavy chain. We evaluated the accessibility of the oligomannose...

Bibliografski detalji
Glavni autori:	Arnold, J, Radcliffe, C, Wormald, M, Royle, L, Harvey, D, Crispin, M, Dwek, R, Sim, R, Rudd, P
Format:	Journal article
Jezik:	English
Izdano:	2004

Slični predmeti

Human serum IgM glycosylation: identification of glycoforms that can bind to mannan-binding lectin.
od: Arnold, J, i dr.
Izdano: (2005)

IgM glycoforms which can bind to immobilised Mannan Binding Lectin
od: Arnold, J, i dr.
Izdano: (2006)

A potential survival strategy for human follicular lymphoma cells involving oligomannose glycans in the antigen-binding site
od: Radcliffe, C, i dr.
Izdano: (2005)

Human follicular lymphoma cells contain oligomannose glycans in the antigen-binding site of the B-cell receptor.
od: Radcliffe, C, i dr.
Izdano: (2007)

N-glycosylation of serum proteins for the assessment of patients with IgD multiple myeloma
od: Jie Chen, i dr.
Izdano: (2017-12-01)

IgD/FcδR is involved in T-cell acute lymphoblastic leukemia and regulated by IgD-Fc-Ig fusion protein
od: Yujing Wu, i dr.
Izdano: (2023-03-01)

Isolation of a mannose-binding and IgE- and IgM-reactive lectin from the seeds of Artocarpus integer
od: Lim, S.B., i dr.
Izdano: (1997)

Glycosylation influences the lectin activities of the mannose receptor
od: Yunpeng, Y, i dr.
Izdano: (2005)

Envelope glycans of immunodeficiency virions are almost entirely oligomannose antigens
od: Doores, K, i dr.
Izdano: (2010)

Glycosylation influences the lectin activities of the macrophage mannose receptor.
od: Su, Y, i dr.
Izdano: (2005)

On the complexity of IgE: The role of structural flexibility and glycosylation for binding its receptors
od: Kevin Plattner, i dr.
Izdano: (2023-03-01)

Serum IgD concentrations in immunodeficiency diseases
od: O Sanal, i dr.
Izdano: (1990-07-01)

Anaplastic morphology in IgD multiple myeloma
od: Verónica Roldán Galiacho, i dr.
Izdano: (2023-10-01)

Differential Expression of IgM and IgD Discriminates Two Subpopulations of Human Circulating IgM+IgD+CD27+ B Cells That Differ Phenotypically, Functionally, and Genetically
od: Diana Bautista, i dr.
Izdano: (2020-05-01)

The impact of glycosylation on the biological function and structure of human immunoglobulins.
od: Arnold, J, i dr.
Izdano: (2007)

CCR7A defines a subpopulation of IgD+IgM- B cells with higher IgD secreting capacity in the rainbow trout skin
od: Esther Morel, i dr.
Izdano: (2025-02-01)

Antileishmanial IgG and IgE antibodies recognize predominantly carbohydrate epitopes of glycosylated antigens in visceral leishmaniasis
od: AM Atta, i dr.
Izdano: (2004-08-01)

Anti-IgE therapy for IgE-mediated allergic diseases: from neutralizing IgE antibodies to eliminating IgE+ B cells
od: Jiayun Hu, i dr.
Izdano: (2018-07-01)

Teleost IgD+IgM− B cells in gills and skin have a plasmablast profile, but functionally and phenotypically differ from IgM+IgD− B cells in these sites
od: J. Germán Herranz-Jusdado, i dr.
Izdano: (2023-08-01)

Increased expression of surface IgM but not IgD or IgG on human B cells in response to IL-4.
od: Shields, J, i dr.
Izdano: (1989)

Detection of intracellular IgD using flow cytometry could be a novel and supplementary method to diagnose IgD multiple myeloma
od: Wei Wang, i dr.
Izdano: (2018-06-01)

Regulation of IgE activity in inhalational tolerance via formation of IgG anti-IgE/IgE immune complexes
od: Sonali J. Bracken, i dr.
Izdano: (2018-05-01)

Tuning IgE: IgE-Associating Molecules and Their Effects on IgE-Dependent Mast Cell Reactions
od: Tomoaki Ando, i dr.
Izdano: (2021-07-01)

Hyper-IgD syndrome and hereditary periodic fever syndromes
od: R. Scolozzi, i dr.
Izdano: (2004-09-01)

IgE glycans promote anti-IgE IgG autoantibodies that facilitate IgE serum clearance via Fc Receptors
od: Kevin Plattner, i dr.
Izdano: (2022-12-01)

IgE-mediated Chronic Allergic Inflammation (IgE-CAI)
od: Yasuyo Harada, i dr.
Izdano: (2012-10-01)

Human complement factor I glycosylation: structural and functional characterisation of the N-linked oligosaccharides.
od: Tsiftsoglou, SA, i dr.
Izdano: (2006)

Regulation of T Cell Activities in Rheumatoid Arthritis by the Novel Fusion Protein IgD-Fc-Ig
od: Jing Zhang, i dr.
Izdano: (2020-05-01)

IgD attenuates the IgM-induced anergy response in transitional and mature B cells
od: Zahra Sabouri, i dr.
Izdano: (2016-11-01)

IgE-Related Chronic Diseases and Anti-IgE-Based Treatments
od: Arnau Navinés-Ferrer, i dr.
Izdano: (2016-01-01)

Self-reactive IgE and anti-IgE therapy in autoimmune diseases
od: Anna Olewicz-Gawlik, i dr.
Izdano: (2023-01-01)

IgD Multiple Myeloma Paraproteinemia as a Cause of Myositis
od: I. Colombo, i dr.
Izdano: (2010-01-01)

Aggressive FLC Escape in a Patient with IgD Myeloma
od: Cédric Farges, i dr.
Izdano: (2015-01-01)

The remnant of the European rabbit (Oryctolagus cuniculus) IgD gene.
od: Dennis K Lanning, i dr.
Izdano: (2017-01-01)

Nummular keratopathy in a patient with Hyper-IgD Syndrome
od: Culican Susan M, i dr.
Izdano: (2009-08-01)

Clinical characteristics and survival of patients with IgD multiple myeloma
od: Yi Li, i dr.
Izdano: (2021-04-01)

Primary Immune Responses and Affinity Maturation Are Controlled by IgD
od: Timm Amendt, i dr.
Izdano: (2021-08-01)

Glycosylation and prion protein.
od: Rudd, P, i dr.
Izdano: (2002)

IgD<sup>+</sup>IgM<sup>−</sup> B Cells in Common Variable Immunodeficiency
od: Taissa de M. Kasahara, i dr.
Izdano: (2024-02-01)

Recombinant soluble form of the high-affinity IgE receptor α subunit and anti-IgE antibody inhibit IgE synthesis by IgE-expressing B cells through distinct pathways
od: Keiichi Kajiwara, i dr.
Izdano: (2002-01-01)